Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manu Smriti Singh

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Therapeutic Delivery|January 16, 2016
siRNA delivery: current trends and future perspectivesManu Smriti Singh, Dan Peer
Current Opinion in Biotechnology|January 17, 2016
RNA nanomedicines: the next generation drugs?Manu Smriti Singh, Dan Peer
International Journal of Pharmaceutics|December 2, 2014
Cargoing P-gp inhibitors via nanoparticle sensitizes tumor cells against doxorubicinManu Smriti Singh, Alf Lamprecht
Drug Development and Industrial Pharmacy|June 13, 2015
P-glycoprotein inhibition of drug resistant cell lines by nanoparticlesManu Smriti Singh, Alf Lamprecht
Immunotargets and Therapy|July 30, 2016
Nanocarrier-based immunotherapy in cancer management and researchManu Smriti Singh, Sangeeta Bhaskar
Frontiers in Pharmacology|May 20, 2024
Deciphering the functional role of clinical mutations in ABCB1, ABCC1, and ABCG2 ABC transporters in endometrial cancerAayushi Gupta, Manu Smriti Singh, Bipin Singh
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 16, 2015
Evaluation of dual P-gp-BCRP inhibitors as nanoparticle formulationManu Smriti Singh, Kapil Juvale, Michael Wiese, et al.
International Journal of Pharmaceutics|February 5, 2013
Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse modelAniruddha Roy, Manu Smriti Singh, Pramod Upadhyay, et al.
Nanotoxicology|February 24, 2026
Emerging use of bio-nanomaterials for brain pathologiesLaiba Noor, Manu Smriti Singh, Arun Upadhyay, et al.
Molecular Pharmaceutics|September 9, 2010
Combined chemo-immunotherapy as a prospective strategy to combat cancer: a nanoparticle based approachAniruddha Roy, Manu Smriti Singh, Pramod Upadhyay, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Therapeutic Delivery|January 16, 2016
siRNA delivery: current trends and future perspectivesManu Smriti Singh, Dan Peer
Current Opinion in Biotechnology|January 17, 2016
RNA nanomedicines: the next generation drugs?Manu Smriti Singh, Dan Peer
International Journal of Pharmaceutics|December 2, 2014
Cargoing P-gp inhibitors via nanoparticle sensitizes tumor cells against doxorubicinManu Smriti Singh, Alf Lamprecht
Drug Development and Industrial Pharmacy|June 13, 2015
P-glycoprotein inhibition of drug resistant cell lines by nanoparticlesManu Smriti Singh, Alf Lamprecht
Immunotargets and Therapy|July 30, 2016
Nanocarrier-based immunotherapy in cancer management and researchManu Smriti Singh, Sangeeta Bhaskar
Frontiers in Pharmacology|May 20, 2024
Deciphering the functional role of clinical mutations in ABCB1, ABCC1, and ABCG2 ABC transporters in endometrial cancerAayushi Gupta, Manu Smriti Singh, Bipin Singh
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 16, 2015
Evaluation of dual P-gp-BCRP inhibitors as nanoparticle formulationManu Smriti Singh, Kapil Juvale, Michael Wiese, et al.
International Journal of Pharmaceutics|February 5, 2013
Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse modelAniruddha Roy, Manu Smriti Singh, Pramod Upadhyay, et al.
Nanotoxicology|February 24, 2026
Emerging use of bio-nanomaterials for brain pathologiesLaiba Noor, Manu Smriti Singh, Arun Upadhyay, et al.
Molecular Pharmaceutics|September 9, 2010
Combined chemo-immunotherapy as a prospective strategy to combat cancer: a nanoparticle based approachAniruddha Roy, Manu Smriti Singh, Pramod Upadhyay, et al.
Pageof 3